Company Introduction
Established in 2002, ASI is a bio-chemical company specializing in recombinant technologies, biocatalysis and chiral technologies. ASI develops and manufactures recombinant human protein,Amino acid derivatives, specialty Amino acids, peptide fragments, and proprietary custom chiral intermediates primarily for the pharmaceutical and industries. ASI's domestic and international customer base includes major pharmaceutical and emerging biopharmaceutical companies, as well as contract drug synthesis firms. ASI also supplies catalog quantities of specialty products to research institutions, universities and drug discovery firms. Our production capabilities integrated from 'mg to tons'. ASI's products are used in peptide, peptidomimetic small molecule and other drugs under development or on the market for the treatment of AIDS, cancer, cardiovascular and other diseases.ASI is your reliable partner because we are honest in business, our goal is complete customer satisfaction in the cost-effective manufacture and delivery of pharmaceutical fine chemicals and intermediates. We have assembled a key combination of people, plant and processes to deliver the innovative technology, manufacturing capability and consistent quality necessary to achieve this goal. Ultimate satisfaction of our customers is what we has been always pursueing.
Contact Information
- - Address
Room 316, Dongxin Mansion,121 kaixuan Road Hangzhou, Zhejiang
- - Country/Region
China
- - Phone
86 - 571 - 86976607
- - Fax
86 - 571 - 86976607
- - Contact Bruce Lee
EC21 Membership Information
- - Membership Class Free Member
- - Membership Year 22 years
- - Last Online 4 months ago
- - EC21 Registered Date Nov 12. 2004
- - Authentication Unverified
- - EC21 Registered IP
115.197.216.***
This is
ASI BIO-TECH CO., LTD‘s IP address when
ASI BIO-TECH CO., LTD joined EC21.com.
- Geolocation based on IP address:
China
Please use above information to identify fraud company with rough assumption. It has 99.8% accuracy on a country level.
EC21 is always do our best to become the clean B2B market.